Jiangdong Qiu

554 total citations
32 papers, 365 citations indexed

About

Jiangdong Qiu is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Jiangdong Qiu has authored 32 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 15 papers in Cancer Research and 12 papers in Molecular Biology. Recurrent topics in Jiangdong Qiu's work include Pancreatic and Hepatic Oncology Research (20 papers), Cancer Genomics and Diagnostics (9 papers) and Pancreatitis Pathology and Treatment (5 papers). Jiangdong Qiu is often cited by papers focused on Pancreatic and Hepatic Oncology Research (20 papers), Cancer Genomics and Diagnostics (9 papers) and Pancreatitis Pathology and Treatment (5 papers). Jiangdong Qiu collaborates with scholars based in China, Austria and United Kingdom. Jiangdong Qiu's co-authors include Taiping Zhang, Yueze Liu, Wenhao Luo, Lianfang Zheng, Gang Yang, Zhe Cao, Lei You, Jinxin Tao, Dan Su and Fangyu Zhao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Free Radical Biology and Medicine.

In The Last Decade

Jiangdong Qiu

30 papers receiving 362 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiangdong Qiu China 13 187 168 138 62 58 32 365
Yaping Guan China 11 156 0.8× 241 1.4× 129 0.9× 51 0.8× 39 0.7× 25 431
Bao‐Ye Sun China 12 104 0.6× 169 1.0× 136 1.0× 77 1.2× 49 0.8× 22 370
Yunfeng Li China 8 199 1.1× 209 1.2× 139 1.0× 87 1.4× 53 0.9× 15 416
Madison Canning United States 3 198 1.1× 142 0.8× 89 0.6× 129 2.1× 24 0.4× 5 372
Yamin Qiao China 8 135 0.7× 208 1.2× 145 1.1× 111 1.8× 39 0.7× 11 383
Fengqing Fu China 11 195 1.0× 260 1.5× 196 1.4× 165 2.7× 27 0.5× 27 516
Tiepeng Li China 11 219 1.2× 149 0.9× 85 0.6× 129 2.1× 32 0.6× 37 428
Shingo Togano Japan 10 107 0.6× 124 0.7× 72 0.5× 50 0.8× 41 0.7× 27 256

Countries citing papers authored by Jiangdong Qiu

Since Specialization
Citations

This map shows the geographic impact of Jiangdong Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiangdong Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiangdong Qiu more than expected).

Fields of papers citing papers by Jiangdong Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiangdong Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiangdong Qiu. The network helps show where Jiangdong Qiu may publish in the future.

Co-authorship network of co-authors of Jiangdong Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiangdong Qiu. A scholar is included among the top collaborators of Jiangdong Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiangdong Qiu. Jiangdong Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Shitao, et al.. (2025). Organoids in the research of pancreatic neoplasms: cultivation, applications, and limitations. Cancer Letters. 632. 217968–217968.
2.
Qiu, Jiangdong, Yifan Fu, Jun Wang, et al.. (2024). Single-cell RNA-seq reveals heterogeneity in metastatic renal cell carcinoma and effect of anti-angiogenesis therapy in the pancreas metastatic lesion. Cancer Letters. 601. 217193–217193. 8 indexed citations
3.
Wang, Ruobing, Guangyu Chen, Yueze Liu, et al.. (2024). FBXO32 Stimulates Protein Synthesis to Drive Pancreatic Cancer Progression and Metastasis. Cancer Research. 84(16). 2607–2625. 4 indexed citations
4.
Luo, Wenhao, Hao Chen, Zhe Cao, et al.. (2024). Advances in Screening and Early Diagnosis of Pancreatic Cancer. 3(3). 154–162.
5.
Su, Dan, Jiangdong Qiu, Gang Yang, et al.. (2024). Ribosome profiling: a powerful tool in oncological research. Biomarker Research. 12(1). 11–11. 8 indexed citations
6.
Zhao, Fangyu, Wenhao Luo, Jiangdong Qiu, et al.. (2024). Human Equilibrative Nucleoside Transporter 1: Novel Biomarker and Prognostic Indicator for Patients with Gemcitabine-Treated Pancreatic Cancer. Cancer Management and Research. Volume 16. 651–661. 1 indexed citations
7.
Su, Dan, Ruobing Wang, Jiangdong Qiu, et al.. (2024). E3 ubiquitin ligase RBCK1 confers ferroptosis resistance in pancreatic cancer by facilitating MFN2 degradation. Free Radical Biology and Medicine. 221. 136–154. 10 indexed citations
8.
Fu, Yifan, Jinxin Tao, Jiangdong Qiu, et al.. (2024). Multiomics integration reveals NETosis heterogeneity and TLR2 as a prognostic biomarker in pancreatic cancer. npj Precision Oncology. 8(1). 109–109. 13 indexed citations
9.
Ding, Jie, Jiangdong Qiu, Zhixin Hao, et al.. (2023). Comparing the clinical value of baseline [68 Ga]Ga-FAPI-04 PET/CT and [18F]F-FDG PET/CT in pancreatic ductal adenocarcinoma: additional prognostic value of the distal pancreatitis. European Journal of Nuclear Medicine and Molecular Imaging. 50(13). 4036–4050. 16 indexed citations
10.
Ding, Jie, Jiangdong Qiu, Zhixin Hao, et al.. (2023). Prognostic value of preoperative [68 Ga]Ga-FAPI-04 PET/CT in patients with resectable pancreatic ductal adenocarcinoma in correlation with immunohistological characteristics. European Journal of Nuclear Medicine and Molecular Imaging. 50(6). 1780–1791. 26 indexed citations
11.
Chen, Guangyu, Yueze Liu, Dan Su, et al.. (2023). Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic cancer. Cellular Oncology. 46(6). 1691–1708. 1 indexed citations
12.
Qiu, Jiangdong, Mengyu Feng, Gang Yang, et al.. (2023). PRKRA promotes pancreatic cancer progression by upregulating MMP1 transcription via the NF-κB pathway. Heliyon. 9(6). e17194–e17194. 5 indexed citations
13.
Luo, Wenhao, Hao Chen, Jun Wang, Jiangdong Qiu, & Taiping Zhang. (2023). Comprehensive study of clinical features, prognostic factors, and survival in patients with pancreatic solid pseudopapillary neoplasms based on the 2019 WHO classification. Journal of Cancer Research and Clinical Oncology. 149(13). 12393–12404. 2 indexed citations
14.
Luo, Wenhao, Jun Wang, Hao Chen, et al.. (2023). Novel strategies optimize immunotherapy by improving the cytotoxic function of T cells for pancreatic cancer treatment. Cancer Letters. 576. 216423–216423. 13 indexed citations
15.
Wang, Jun, Hao Chen, Liyuan Ye, et al.. (2023). Epidemiology of pancreatic cancer: New version, new vision. Chinese Journal of Cancer Research. 35(5). 438–450. 22 indexed citations
16.
17.
Chen, Guangyu, Gang Yang, Junyu Long, et al.. (2021). Comprehensive Analysis of Autophagy-Associated lncRNAs Reveal Potential Prognostic Prediction in Pancreatic Cancer. Frontiers in Oncology. 11. 596573–596573. 7 indexed citations
18.
19.
Liu, Yueze, Mengyu Feng, Hao Chen, et al.. (2020). Mechanistic target of rapamycin in the tumor microenvironment and its potential as a therapeutic target for pancreatic cancer. Cancer Letters. 485. 1–13. 12 indexed citations
20.
Cao, Zhe, Jiangdong Qiu, Gang Yang, et al.. (2020). MiR-135a biogenesis and regulation in malignancy: a new hope for cancer research and therapy. Cancer Biology and Medicine. 17(3). 569–582. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yaping Guan Breakdown of academic impact, for papers by Bao‐Ye Sun Breakdown of academic impact, for papers by Yunfeng Li Breakdown of academic impact, for papers by Madison Canning Breakdown of academic impact, for papers by Yamin Qiao Breakdown of academic impact, for papers by Fengqing Fu Breakdown of academic impact, for papers by Tiepeng Li Breakdown of academic impact, for papers by Shingo Togano
Rankless by CCL
2026